UBER DIE MAGENVERANDERUNGEN BEI DER ADDISONSCHEN KRANKHEIT

[1] FEYRTER F, IN PRESS ACTA NEUROV

[2] FEYRTER F, 1952, MUNCH MED WSCHR, P4

[3] Feyrter F, 1938, DIFFUSE ENDOKRINE EP

[4] FEYRTER F, 1951, WIEN MED WSCHR, P912

[5] FEYRTER F, 1946, WIEN Z INN MED, P10

[6] JORES A, 1942, KLIN ENDOKRINOLOGIE

[7] LAUDA E, 1951, LEHRBUCH INNEREN MED, V3

[8] ROWNTREE, 1941, HDB INNEREN MED 1, V6

[9] SUTHERLAND WE, 1949, J BIOLOGICAL CHEMIST, V180, P825

[10] THADDEA S, 1939, NEUE DTSCH KLINIK

[1] FEYRTER F, IN PRESS ACTA NEUROV

[2] FEYRTER F, 1952, MUNCH MED WSCHR, P4

[3] Feyrter F, 1938, DIFFUSE ENDOKRINE EP

[4] FEYRTER F, 1951, WIEN MED WSCHR, P912

[5] FEYRTER F, 1946, WIEN Z INN MED, P10

[6] JORES A, 1942, KLIN ENDOKRINOLOGIE

[7] LAUDA E, 1951, LEHRBUCH INNEREN MED, V3

[8] ROWNTREE, 1941, HDB INNEREN MED 1, V6

[9] SUTHERLAND WE, 1949, J BIOLOGICAL CHEMIST, V180, P825

[10] THADDEA S, 1939, NEUE DTSCH KLINIK